Abstract
Although several familial cancer genes with high-penetrance mutations have been identified, the major genetic component of susceptibility to sporadic cancers is attributable to low-penetrance alleles. These ‘weak’ tumor susceptibility genes do not segregate as single Mendelian traits and are therefore difficult to find in studies of human populations. Previously, we have proposed that a combination of germline mapping and analysis of allele-specific imbalance in tumors may be used to refine the locations of susceptibility genes using mouse models of cancer. Here, we have used linkage analysis and congenic mouse strains to map the major skin tumor susceptibility locus Skts1 within a genetic interval of 0.9 cM on proximal chromosome 7. This interval lies in an apparent recombination cold spot, and corresponds to a physical distance of about 15 Mb. We therefore, used patterns of allele-specific imbalances in tumors from backcross and congenic mice to refine the location of Skts1. We demonstrate that this single tumor modifier locus has a dramatic effect on the allelic preference for imbalance on chromosome 7, with at least 90% of tumors from the congenics showing preferential gain of markers on the chromosome carrying the susceptibility variant. Importantly, these alterations enabled us to refine the location of Skts1 at higher resolution than that attained using the congenic mice. We conclude that low-penetrance susceptibility genes can have strong effects on patterns of allele-specific somatic genetic changes in tumors, and that analysis of the directionality of these somatic events provides an important and rapid route to identification of germline genetic variants that confer increased cancer risk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Balmain A . (2002). Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108: 145–152.
Balmain A, Gray J, Ponder BA . (2003). The genetics and genomics of cancer. Nat Genet 33: 238–244.
Cormier RT, Bilger A, Lillich AJ, Halberg RB, Hong KH, Gould KA et al. (2000). The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene 19: 3182–3192.
Demant P . (2003). Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat Rev Genet 4: 721–734.
Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C et al. (1993). Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631–639.
Dragani TA . (2003). 10 years of mouse cancer modifier loci: human relevance. Cancer Res 63: 3011–3018.
Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F et al. (2003). Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Gene 34: 403–412.
Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM et al. (2005). Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis 26: 1368–1373.
Fijneman RJ, de Vries SS, Jansen RC, Demant P . (1996). Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet 14: 465–467.
Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM et al. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643–646.
Hienonen T, Salovaara R, Mecklin JP, Jarvinen H, Karhu A, Aaltonen LA . (2006). Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers. Int J Cancer 118: 505–508.
Kemp CJ, Fee F, Balmain A . (1993). Allelotype analysis of mouse skin tumors using polymorphic microsatellites: sequential genetic alterations on chromosomes 6, 7, and 11. Cancer Res 53: 6022–6027.
Knudson AG . (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823.
Legare ME, Frankel WN . (2000). Multiple seizure susceptibility genes on chromosome 7 in SWXL-4 congenic mouse strains. Genomics 70: 62–65.
Mao JH, Balmain A . (2003). Genomic approaches to identification of tumour-susceptibility genes using mouse models. Curr Opin Genet Dev 13: 14–19.
Mao JH, Saunier EF, de Koning JP, McKinnon MM, Higgins MN, Nicklas K et al. (2006). Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. Proc Natl Acad Sci USA 103: 8125–8130.
Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, Balmain A . (1995). Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat Genet 10: 424–429.
Nagase H, Mao JH, Balmain A . (1999). A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. Proc Natl Acad Sci USA 96: 15032–15037.
Nagase H, Mao JH, Balmain A . (2003). Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res 63: 4849–4853.
Peto J . (2001). Cancer epidemiology in the last century and the next decade. Nature 411: 390–395.
Ponder BA . (2001). Cancer genetics. Nature 411: 336–341.
Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikos T et al. (2002). Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 31: 295–300.
Saran A, Spinola M, Pazzaglia S, Peissel B, Tiveron C, Tatangelo L et al. (2004). Loss of tyrosinase activity confers increased skin tumor susceptibility in mice. Oncogene 23: 4130–4135.
Silver LM . (1995). Mouse Genetics: Concepts and Applications. Oxford University Press: Oxford.
To MD, Perez-Losada J, Mao JH, Hsu J, Jacks T, Balmain A . (2006). A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat Genet 38: 926–930.
Vogel SN, Wax JS, Perera PY, Padlan C, Potter M, Mock BA . (1994). Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene. Infect Immun 62: 4454–4459.
Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P et al. Mouse Genome Sequencing Consortium. (2002). Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520–562.
Yu A, Zhao C, Fan Y, Jang W, Mungall AJ, Deloukas P et al. (2001). Comparison of human genetic and sequence-based physical maps. Nature 409: 951–953.
Acknowledgements
We thank R del Rosario and R Contreras for assistance with animal husbandry. This work was supported by an NCI Mouse Models of Human Cancer Consortium Grant (U01 CA84244). The early development of the congenic lines was funded by Cancer Research UK at the Beatson Institute (Glasgow, Scotland). JPdK was supported by a research fellowship through the Dutch Cancer Society. JHM is the recipient of a Leukemia & Lymphoma Society Fellowship. AB acknowledges support of the Barbara Bass Bakar Endowed Chair of Cancer Genetics.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests statement
The authors declare that they have no competing financial interests.
Rights and permissions
About this article
Cite this article
de Koning, J., Wakabayashi, Y., Nagase, H. et al. Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus. Oncogene 26, 4171–4178 (2007). https://doi.org/10.1038/sj.onc.1210206
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210206
Keywords
This article is cited by
-
Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications
Nature Protocols (2009)